Market Overview:
The global atrial fibrillation ablation device market is expected to grow from USD 1.5 billion in 2018 to USD 3.2 billion by 2030, at a CAGR of 10.8% during the forecast period. The growth of this market is mainly attributed to the increasing incidence of AFib, technological advancements in ablation devices, and rising demand for minimally invasive procedures. However, the high cost of ablation devices and limited reimbursement policies are restraining the growth of this market. Based on type, the global atrial fibrillation ablation device market is segmented into catheter ablation and maze surgery. Catheter ablations are expected to account for a larger share than maze surgeries during the forecast period owing to their lower cost and shorter procedural time as compared with maze surgeries. Based on application, hospitals accounted for a larger share than ambulatory surgical centers (ASCs) in 2017 owing to higher patient volumes.
Product Definition:
Atrial Fibrillation Ablation Device is a medical device used to treat atrial fibrillation. The device delivers energy to the heart tissue, which destroys the abnormal cells that cause atrial fibrillation. This can help restore the heart's normal rhythm and improve symptoms.
Catheter Ablation:
Ablation is a surgical procedure wherein the tissue or organ is destroyed by the application of heat. It's most commonly used for treatment of slow heartbeats (bradycardia) and irregular heartbeats (irregular heartbeat, also called arrhythmia). The technique has been evolving over many years with technological advancements in catheter ablation devices. This has led to better patient outcomes and reduction in procedural costs.
Maze Surgery:
Maze surgery is a minimally invasive surgical procedure used to treat atrial fibrillation. It involves mapping the electrical activity of the heart and then cutting off all the pathways between chambers of heart which helps in reducing irregular heartbeat. This device is FDA approved for treating paroxysmal (sudden) atrial fibrillation, permanent atrial fibrillation, and low output syndrome associated with chronic cardiac failure.
Application Insights:
Based on application, the global atrial fibrillation ablation device market is segmented into hospitals, ambulatory surgical centers and other. The hospitals segment dominated the market in 2017 owing to factors such as increasing prevalence of atrial fibrillation and growing adoption of advanced technologies for its treatment. According to a study published by NCBI in 2018, around 1 in every 5 people suffering from AF is referred for diagnostic evaluation each year. Increasing awareness about this disease coupled with rising availability of advanced treatment options are some of the major factors driving growth in this segment over the forecast period.
The ambulatory surgical centers (ASCs) segment is expected to grow significantly over the forecast period due to an increase in adoption rate among patients with AF across various regions including North America and Europe Pacific countries such as Japan China Australia New Zealand India Canada Brazil France Russia etc.
Regional Analysis:
North America dominated the global market in 2017 owing to the increasing prevalence of AF and its treatment. The U.S., which is a developed economy, has a higher penetration rate of atrial ablation devices as compared to developing economies such as India and China.
Asia Pacific is expected to grow at an exponential rate during the forecast period due to improving healthcare infrastructure & availability of advanced medical products leading towards cost-effective treatment options for patients suffering from paroxysmal disorders such as palpitations & arrhythmia's.
Growth Factors:
- Increasing incidence of atrial fibrillation (AF)
- Growing demand for minimally invasive procedures
- Technological advancements in ablation devices
- Rising awareness about the benefits of atrial fibrillation ablation therapy
- Increasing number of AF-related surgeries
Scope Of The Report
Report Attributes
Report Details
Report Title
Atrial Fibrillation Ablation Device Market Research Report
By Type
Catheter Ablation, Maze Surgery
By Application
Hospitals, Ambulatory Surgical Centers, Other
By Companies
Johnson & Johnson, Abbott, Medtronic, Japan Lifeline, Boston Scientific, Atricure, Biotroik, OSYPKA AG, Cardiofocus, MicroPort EP MedTech, Synaptic Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Atrial Fibrillation Ablation Device Market Report Segments:
The global Atrial Fibrillation Ablation Device market is segmented on the basis of:
Types
Catheter Ablation, Maze Surgery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Abbott
- Medtronic
- Japan Lifeline
- Boston Scientific
- Atricure
- Biotroik
- OSYPKA AG
- Cardiofocus
- MicroPort EP MedTech
- Synaptic Medical
Highlights of The Atrial Fibrillation Ablation Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Catheter Ablation
- Maze Surgery
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Atrial Fibrillation Ablation Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Atrial Fibrillation Ablation Device is a medical device that is used to treat atrial fibrillation. It helps to stop the irregular heart rhythm by destroying the tissue in the heart that causes it.
Some of the major players in the atrial fibrillation ablation device market are Johnson & Johnson, Abbott, Medtronic, Japan Lifeline, Boston Scientific, Atricure, Biotroik, OSYPKA AG, Cardiofocus, MicroPort EP MedTech, Synaptic Medical.
The atrial fibrillation ablation device market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Atrial Fibrillation Ablation Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Atrial Fibrillation Ablation Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Atrial Fibrillation Ablation Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Atrial Fibrillation Ablation Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Atrial Fibrillation Ablation Device Market Size & Forecast, 2020-2028
4.5.1 Atrial Fibrillation Ablation Device Market Size and Y-o-Y Growth
4.5.2 Atrial Fibrillation Ablation Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Catheter Ablation
5.2.2 Maze Surgery
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Atrial Fibrillation Ablation Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Atrial Fibrillation Ablation Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Catheter Ablation
9.6.2 Maze Surgery
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Catheter Ablation
10.6.2 Maze Surgery
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Catheter Ablation
11.6.2 Maze Surgery
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Catheter Ablation
12.6.2 Maze Surgery
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Catheter Ablation
13.6.2 Maze Surgery
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Atrial Fibrillation Ablation Device Market: Competitive Dashboard
14.2 Global Atrial Fibrillation Ablation Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Abbott
14.3.3 Medtronic
14.3.4 Japan Lifeline
14.3.5 Boston Scientific
14.3.6 Atricure
14.3.7 Biotroik
14.3.8 OSYPKA AG
14.3.9 Cardiofocus
14.3.10 MicroPort EP MedTech
14.3.11 Synaptic Medical
